NIH-funded research R15 grant

Understanding how alpha-synuclein affects cell membranes in Parkinson's disease

Official title: PROVIDE NEW INSIGHTS IN ALPHA-SYNUCLEIN INDUCED CELL MEMBRANE DISRUPTION USING SCANNING ION CONDUCTANCE MICROSCOPY AND SURFACE PLASMON RESONANCE MICROSCOPY

Funded at California State University Los Angeles · NIH-10974782 · Data updated 2026-11-12

This study is looking at how a protein called alpha-synuclein, which is connected to Parkinson's disease, affects brain cells and how things like tiny plastic particles in the environment might make it worse, all to find new ways to help people with Parkinson's.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionCalifornia State University Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startSeptember 30, 2020
Project endAugust 31, 2027
Funding year2024
Award (this year)$438,000
NIH project number2R15NS120157-02
Project IDNIH-10974782 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Parkinson's disease or those at risk due to genetic or environmental factors.

Less likely to help

Patients with other neurodegenerative disorders unrelated to alpha-synuclein may not benefit from this research.

What this research studies

This research investigates the role of alpha-synuclein, a protein linked to Parkinson's disease, in disrupting neuronal cell membranes. Using advanced imaging techniques like scanning ion conductance microscopy and surface plasmon resonance microscopy, the study aims to explore how different forms of alpha-synuclein, particularly its phosphorylated variant, impact neuronal health. The research will also examine the effects of environmental toxins, such as nanoplastics, on alpha-synuclein aggregation and its interactions with cell membranes. By deepening our understanding of these mechanisms, the research seeks to identify potential therapeutic targets for Parkinson's disease.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating Parkinson's disease.

How similar studies have gone: Previous research has shown promising results in understanding alpha-synuclein's role in neurodegeneration, indicating that this approach has potential for success.

Where this research is happening

  • California State University Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Wang, Yixian — California State University Los Angeles
  • Study coordinator: Wang, Yixian

Related research

Other NIH-funded projects on the same topics.

  • A program to support underrepresented students in biomedical research careers

    This program is designed to help students from East Los Angeles College and Pasadena City College who are underrepresented, disabled, or facing challenges, by giving them hands-on experience in biomedical research and support as they move on to California State University Los Angeles, so they can build their skills and

    NIH research California State University Los Angeles · Los Angeles, United States · NIH-10892922

  • Program to help minority students transition to Ph.D. programs in biomedical sciences

    This program is helping minority students move from master's programs to Ph.D. programs in biomedical research by providing training and support to boost their skills and connect them with the research community, so they can build successful careers in this important field.

    NIH research California State University Los Angeles · Los Angeles, United States · NIH-10890820

  • A summer program for undergraduate students to explore research in human development and disabilities.

    The SPROUT program at Cal State LA gives undergraduate students, especially those from underrepresented backgrounds, a chance to dive into hands-on research in health and child development while also helping them build important skills for their future careers.

    NIH research California State University Los Angeles · Los Angeles, United States · NIH-10437858

  • Repairing harmful genetic mutations in mitochondrial RNA

    This study is exploring a new way to fix genetic mistakes in mitochondrial RNA that cause diseases like Leigh syndrome, using specially designed plant proteins to help repair these issues, which could lead to better treatments for people with these genetic disorders.

    NIH research California State University Los Angeles · Los Angeles, United States · NIH-10359636

  • How bilingual preschoolers perceive and produce speech sounds in Spanish and English

    This study looks at how young kids who speak both Spanish and English learn to make and understand speech sounds as they start using more English, helping us understand their language skills better and what helps them learn.

    NIH research California State University Los Angeles · Los Angeles, United States · NIH-10200570

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.